Baumann Oliver Rolf insider trades
Baumann Oliver Rolf has filed 1 Form 4 with the SEC that we hold, all for Veraxa Biotech AG - Post de-SPAC (VRXA), as Director. Across all of them we count 1 purchase worth $75.0K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($75.0K) and 0 sales ($0). The largest single trade was a purchase of 50,000 shares of Veraxa Biotech AG - Post de-SPAC worth $75.0K, dated 2026-08-27. The first filing on our record is dated 2026-08-31 and the latest 2026-08-31.
Veraxa Biotech AG - Post de-SPAC (VRXA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-27 | P, purchase reported on Form 4 | 50,000 | $75.0K | 2026-08-31 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2129436) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms